A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study

Maurizio Coppola and Raffaella Mondola

 

Abstract

Psychomotor agitation is a medical condition associated with a wide range of psychiatric and non psychiatric diseases including: mood disorders, schizophrenia, personality disorders and drug dependence. In our pilot, open-label study, we evaluated the effect of a single dose of sublingual asenapine in bipolar patients affected by withdrawal syndrome induced psychomotor agitation resistant to the treatment with agonist medicines (methadone, gamma hydroxybutyrate and benzodiazepines).

Published on: May 15, 2017
doi: 10.17756/jrdsas.2017-035
Citation: Coppola M, Mondola R. 2017. A Single Dose of Asenapine for the Treatment of Bipolar Patients Affected by Withdrawal Syndrome Induced Psychomotor Agitation: A Pilot, Open-Label Study. J Reward Defic Syndr Addict Sci 3(1): 14-16.
 
270
Downloads